NewsResearch

Claude adds protein design to its resume

The Rundown AI

Anthropic's Claude models successfully ran autonomous protein-design campaigns, achieving 22-35% success rates on molecular targets—significantly outperforming industry norms of 10-15%. The newsletter also covers Uber's "Agentic Pods" approach to controlling AI costs, the Loop Method for improving ChatGPT workflows, and Replit's new Free Mode leveraging cheaper efficient models.

Summary

Anthropic published research demonstrating that Claude models can autonomously execute early-stage drug discovery work, specifically protein design campaigns. Using Claude's Mythos Preview and Opus 4.8 models with a single expert-written prompt, internet access, and tools, the system identified molecular candidates with success rates of 22-35% for binding to targets—substantially higher than the typical 10-15% industry baseline. The actual lab validation was conducted by Twist Bioscience and Adaptyv Bio across 15 targets, with 14 showing working molecules. Claude Opus 5 separately demonstrated the ability to read raw instrument files without specialized lab software, measuring sample purity at 96.4% in 19 minutes versus four days for traditional lab reporting. CEO Dario Amodei had recently claimed Anthropic's biology work was months away from "early glimmers," but this research delivered results within days of that statement.

The newsletter features Nate Grahek's analysis of Uber's response to overspending on AI by 300% of their 2026 budget in four months. Uber's CTO Praveen Neppalli Naga created "Agentic Pods"—two-person teams pairing an AI-proficient engineer with domain experts from Finance, Marketing, or Operations—to run 10-day sprints on specific projects. This approach yielded a financial pacing report that previously took two full days to produce but now runs in 10 minutes, demonstrating that enterprise organizations must earn incremental wins before pursuing larger AI initiatives.

The Loop Method is presented as a technique for improving repeated ChatGPT workflows through iterative self-improvement, using adversarial review from sub-agent panels to refine processes until a defined completion state is reached. Replit launched Free Mode on its paid plans, routing routine tasks to OpenAI's cheaper GPT-5.6 Luna model without consuming user credits, allowing 30x usage scaling on lower tiers while reserving premium models for complex work. Additional news includes Z AI's GLM-5.3 ranking fourth globally among AI models, AWS re:Invent offering 2,200+ hands-on sessions, Cerebras releasing a 30x faster AI computer, and OpenAI introducing Private Safety Processing for content moderation without staff visibility.

About this episode

PLUS: Use the Loop Method for better ChatGPT results

Key Insights

  • Anthropic's Claude models achieved protein-design success rates of 22-35% on lab-validated targets, exceeding the 10-15% industry standard, while operating autonomously with minimal human intervention beyond an initial prompt.
  • Uber discovered that unsubsidized frontier models are prohibitively expensive for unrestricted organizational use, leading them to restrict AI access to specialized two-person Agentic Pods running 10-day sprints on specific efficiency gains rather than broad deployments.
  • Claude Opus 5 can interpret raw scientific instrument files and perform measurements without requiring proprietary lab software, completing analysis in 19 minutes versus the four-day timeline of traditional lab reporting methods.
  • The economics of AI products are shifting as lower-cost models maintain competitive intelligence levels—Replit's Luna model's 80% price reduction enables 30x usage scaling on basic plans without perceived quality degradation.
  • Dario Amodei's statement that Anthropic's biology work was months away from results was contradicted within days by the publication of functional protein-design research validated in external laboratories.

Topics

Protein design and drug discovery automationEnterprise AI cost management and ROIAI workflow optimization techniquesEfficient model deployment and pricingAutonomous AI system capabilities

Transcript

Good morning, {{ first_name | AI enthusiasts }}, and welcome to our 12,567 new readers. Four days ago, Dario Amodei went on X to say Anthropic's biology work was months away from its first "early glimmers." Did he undersell the timeline? Claude just added protein design to its already lengthy resume, with new research showing the models running an early step of the drug discovery pipeline on their own and producing results that held up in the lab. Reminder: Our next live workshop is today at 2 PM EST — Join and learn how to land your first paid AI consulting gig on Upwork. RSVP here . Anthropic's Claude tackles protein design Nate's Notebook: Uber's tiger team playbook Use the…

Full transcript available for MurmurCast members

Sign Up to Access

More from The Rundown AI

Get AI summaries like this delivered to your inbox daily

Get AI summaries delivered to your inbox

MurmurCast summarizes your YouTube channels, podcasts, and newsletters into one daily email digest.